Cargando…

A systematic review of the international prevalence of BRCA mutation in breast cancer

A systematic review was conducted, summarizing international BRCA 1 or 2 (BRCA1/2) mutation prevalence in breast cancer. Databases (eg, Medline and Embase; N=7) and conferences were searched (January 2012 to December 2017). From 17,872 records, 70 studies were included. In 58 large (N>100) studie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armstrong, Nigel, Ryder, Steve, Forbes, Carol, Ross, Janine, Quek, Ruben GW
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628947/ https://www.ncbi.nlm.nih.gov/pubmed/31372057 http://dx.doi.org/10.2147/CLEP.S206949

Ejemplares similares

A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer
por: Forbes, Carol, et al.
Publicado: (2019)

A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer
por: Lang, Shona H., et al.
Publicado: (2019)

Prevalence of BRCA1 and BRCA2 Mutations in Korean Breast Cancer Patients
por: Ahn, Sei Hyun, et al.
Publicado: (2004)

BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review
por: Neamatzadeh, Hossein, et al.
Publicado: (2015)

Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients
por: Díez, O, et al.
Publicado: (1999)

Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon
por: Jalkh, Nadine, et al.
Publicado: (2012)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece
por: Koumpis, Chrissovaladis, et al.
Publicado: (2011)

Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients
por: Torres, D., et al.
Publicado: (2017)

Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
por: McCrorie, Alan D, et al.
Publicado: (2020)

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial
por: Hurvitz, Sara A., et al.
Publicado: (2019)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia
por: Hernández, Julián Esteban Londoño, et al.
Publicado: (2014)

Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer
por: Abulkhair, Omalkhair, et al.
Publicado: (2018)

Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high‐risk breast cancer
por: Wang, Xiaozhen, et al.
Publicado: (2019)

BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis
por: Zhu, Yaning, et al.
Publicado: (2016)

Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis
por: Abdulrashid, Khadiga, et al.
Publicado: (2019)

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases
Publicado: (2000)

Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation
por: Mansfield, Carol A., et al.
Publicado: (2020)

Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? – a systematic review
por: Oluwagbemiga, Lawal AbdulRazzaq, et al.
Publicado: (2012)

Prevalence of BRCA1 and BRCA2 Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China
por: Ou, Jianghua, et al.
Publicado: (2013)

Endometrial Cancer and BRCA Mutations: A Systematic Review
por: Gasparri, Maria Luisa, et al.
Publicado: (2022)

Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022)

BRCA Mutations and Breast Cancer Prevention
por: Kotsopoulos, Joanne
Publicado: (2018)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018)

Erratum to: Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? – a systematic review
por: Lawal, AbdulRazzaq Oluwagbemiga, et al.
Publicado: (2015)

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis
por: van den Broek, Alexandra J., et al.
Publicado: (2015)

BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2017)

BRCA1/BRCA2 mutation spectrum analysis in South Asia: a systematic review
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
por: Baretta, Zora, et al.
Publicado: (2016)

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource
por: Mann, Graham J, et al.
Publicado: (2006)

Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Prevalence of BRCA1 and BRCA2 Germline Mutations in Patients of African Descent with Early-Onset and Familial Colombian Breast Cancer
por: Vargas, Elizabeth, et al.
Publicado: (2022)

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
por: Young, SR, et al.
Publicado: (2009)

Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer
por: Steinmann, D, et al.
Publicado: (2001)

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008)

Breast cancer prevention in women with a BRCA1 or BRCA2 mutation
por: Metcalfe, Kelly A, et al.
Publicado: (2007)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2012)

Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer
por: Kim, Haeyoung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o7lo4b1apki2ibllhnp8qvbdks